Table 2.

Clinical characteristics of participants from Morwell and Sale.

Characteristic	Morwell (Exposed) N = 336		Sale (Unexposed) N = 162		p-Value
	n	Weighted %	n	Weighted %
History of cardiovascular diseases *
Prior to 2014	113	28.2	62	33	0.559
Since 2014	49	12.6	18	11.8
Diabetes †	84	22.9	29	16.1	0.096
Smoking status
Non-smoker	157	46.4	86	54.1	0.123
Ex-smoker	151	44.6	68	41.4
Current smoker	28	9	8	4.4
Alcohol consumption
Non-drinker	87	25	37	23	0.341
Low risk	125	36.3	50	31.1
High risk	124	38.7	74	46
Taking antihypertensive medications	237	67.8	99	59.7	0.091
Taking lipid-lowering therapy	168	47.7	63	37.1	0.038
Taking anti-inflammatory or immunosuppressant medications	75	20.6	23	12.7	0.031
Engaged in adequate physical activity	150	45.2	98	60.3	0.003
BMI
Underweight/normal	56	17.6	40	24.4	0.105
Overweight	112	33.9	57	36.5
Obese	168	48.5	65	39.1
eGFR
<60 mL/min/1.73 m2	60	17.1	22	13.5	0.323
HbA1c (%)	Weighted Mean	SEM	Weighted Mean	SEM	p-value
	6.1	0.1	5.8	0.1	<0.001

* = Includes self-reported doctor-diagnosis of peripheral vascular disease, stroke/transient ischemic attack, coronary artery disease, myocardial infarction, heart failure, valvular disease, aneurysm and/or rhythm abnormality. ^† = Self-reported doctor diagnosis of diabetes or HbA_1c ≥ 6.5% or taking hypoglycaemic medications. Abbreviations: BMI = body mass index; eGFR = Estimated Glomerular Filtration Rate; HbA_1c = glycosylated Haemoglobin; SEM = Standard error of the mean.